Search research articles
Contact Us
Filters
Showing results (31-40 of 171) with videos related to
Page
of 18
Sort By:
Arzneimittel-Forschung
|
January 1, 1976
[The effect of thyrotrophin releasing hormone versus placebo in combination with basic imipramine therapy of depressive patients]
O Benkert, K H Lücke
Journal of Affective Disorders
|
October 2, 2001
Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil
M J Müller, O Benkert
Social Psychiatry and Psychiatric Epidemiology
|
June 12, 1999
Psychological distress and psychiatric disorders in primary health care patients in East and West Germany 1 year after the fall of the Berlin Wall
M Achberger, M Linden, O Benkert
Psychopharmacologia
|
January 1, 1974
The comparison of thyrotropin releasing hormone, luteinising hormone-releasing hormone and placebo in depressive patients using a double-blind cross-over technique
O Benkert, A Gordon, D Martschke
Neuropharmacology
|
November 1, 1970
Changing hyperactivity response thresholds with substances influencing biogenic amines
O Benkert, R Kerner, N Matussek
International Clinical Psychopharmacology
|
January 1, 1993
A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction
M Philipp, R Kohnen, O Benkert
Acta Psychiatrica Scandinavica
|
May 1, 1993
Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls
A Steiger, F Holsboer, O Benkert
Psychopathology
|
January 1, 1985
Operational diagnosis of endogenous depression. II. Comparison of 8 different operational diagnoses
M Philipp, W Maier, O Benkert
Journal of Clinical Psychopharmacology
|
December 6, 2000
Orlistat in the treatment of psychopharmacologically induced weight gain
I Anghelescu, C Klawe, O Benkert
Neuropharmacology
|
March 1, 1973
Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine
O Benkert, H Gluba, N Matussek
Page
of 18
Search research articles
Search
Showing results (31-40 of 171) with videos related to
Sort By:
Page
of 18
Arzneimittel-Forschung
|
January 1, 1976
[The effect of thyrotrophin releasing hormone versus placebo in combination with basic imipramine therapy of depressive patients]
O Benkert, K H Lücke
Journal of Affective Disorders
|
October 2, 2001
Lower self-reported depression in patients with erectile dysfunction after treatment with sildenafil
M J Müller, O Benkert
Social Psychiatry and Psychiatric Epidemiology
|
June 12, 1999
Psychological distress and psychiatric disorders in primary health care patients in East and West Germany 1 year after the fall of the Berlin Wall
M Achberger, M Linden, O Benkert
Psychopharmacologia
|
January 1, 1974
The comparison of thyrotropin releasing hormone, luteinising hormone-releasing hormone and placebo in depressive patients using a double-blind cross-over technique
O Benkert, A Gordon, D Martschke
Neuropharmacology
|
November 1, 1970
Changing hyperactivity response thresholds with substances influencing biogenic amines
O Benkert, R Kerner, N Matussek
International Clinical Psychopharmacology
|
January 1, 1993
A comparison study of moclobemide and doxepin in major depression with special reference to effects on sexual dysfunction
M Philipp, R Kohnen, O Benkert
Acta Psychiatrica Scandinavica
|
May 1, 1993
Studies of nocturnal penile tumescence and sleep electroencephalogram in patients with major depression and in normal controls
A Steiger, F Holsboer, O Benkert
Psychopathology
|
January 1, 1985
Operational diagnosis of endogenous depression. II. Comparison of 8 different operational diagnoses
M Philipp, W Maier, O Benkert
Journal of Clinical Psychopharmacology
|
December 6, 2000
Orlistat in the treatment of psychopharmacologically induced weight gain
I Anghelescu, C Klawe, O Benkert
Neuropharmacology
|
March 1, 1973
Dopamine, noradrenaline and 5-hydroxy-tryptamine in relation to motor activity, fighting and mounting behavior. I. L-dopa and DL-threo-dihydroxyphenylserine in combination with Ro 4-4602, pargyline and reserpine
O Benkert, H Gluba, N Matussek
Page
of 18